Sarah Brockbank leads the strategy for Complex Medicines at Medicines Discovery Catapult.
In this role she draws on internal expertise and the external environment, through membership of national programmes and a portfolio of client projects, to develop and implement a core strategy for complex medicines that is responsive to the needs of this emerging area.
Sarah has 35 years’ of experience in the pharmaceutical industry. She is a molecular biologist with a focus mainly in target identification & validation and has worked across a broad range of disease areas. Sarah was a Drug Discovery Project Leader at AstraZeneca, and she also has extensive experience in the leadership and management of large public-private consortia and collaborations.
